OBM Transplantation—A New Hub in the Network of Transplantation Science
Pål Dag Line
Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway
Received: April 7, 2017 | Accepted: April 7, 2017 | Published: April 11, 2017
OBM Transplantation 2017, Volume 1, Issue 1, doi:10.21926/obm.transplant.1701001
Recommended citation: Line PD. OBM Transplantation—A New Hub in the Network of Transplantation Science. OBM Transplantation 2017;1(1):001; doi:10.21926/obm.transplant.1701001.
© 2017 by the author. This is an open access article distributed under the conditions of the Creative Commons by Attribution License, which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is correctly cited.
It is a great pleasure for me as editor in chief to welcome all to the first issue of OBM Transplantation, an open access, peer reviewed journal with a broad focus on organ transplantation and related fields. The ability to cure detrimental disease due to organ failure by transplanting an allogeneic organ, is one of the biggest achievements of modern medicine in the 20th century. One of the characteristics of transplant medicine is the need for multidisciplinary involvement from various branches of clinical medicine as well as basic scientific disciplines. Furthermore, advances in organ transplantation can only come to reality through systematic scientific development.
This is the background for starting OBM Transplantation. The journal aims at covering all types of evidence based scientific studies related to organ transplantation with the aim of providing its readers articles of high quality and relevance, and the authors a service characterized by rapid review and publication. The only way we can achieve this goal is through our readers and contributors, hence we invite all professionals within the field to join in on this effort.
We have decided to start off by publishing a series of special focus issues, covering a field in depth. The first issue is on lung transplantation, and Dr. Morris and coworkers have written a review on anti-HLA antibodies in lung transplantation. The relevance of donor specific antibodies, whether formed pre transplant or occurring after transplantation is a field of increased clinical relevance that most likely influences the long term course after organ transplantation. Therefore, this is not only pertinent to lung transplantation, but has general applicability to all transplanted organs. I invite you to submit your work to OBM Transplantation, an international Open Access journal published quarterly online. For this year, we will publish all accepted manuscripts without any publication fee. Transplant Societies that are not affiliated to a specific journal, are hereby invited to contact us so that we jointly can consider and work towards future cooperation between OBM Transplantation and national/regional transplant societies around the world.
